Roger Faroux

8.3k citations
88 papers · 6.1k · 4 hit papers · h-index 31

Impact in

  • Oncology top 0.5%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Colorectal Cancer Surgical Treatments
    • Cancer Immunotherapy and Biomarkers
  • Hepatology top 5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Colorectal Cancer Treatments and Studies 37
    • Colorectal Cancer Surgical Treatments 11
    • Pancreatic and Hepatic Oncology Research 6
    • Cancer Immunotherapy and Biomarkers 2
    • Hepatocellular Carcinoma Treatment and Prognosis 8

Roger Faroux

83 papers receiving 6k citations

Roger Faroux's Hit Papers

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer 2022 · 225 citations
2250+7+14Years since publication5001k1.5k2k

Peers

Roger Faroux
Comparison fields: 5 of 91
  • Oncology 3.9k
  • Hepatology 265
  • Cancer Research 309
  • Pharmacology 211
  • Geriatrics and Gerontology 67
Replace Benjamin R. Tan with:
Benjamin R. Tan United States
Gianluca Tomasello Italy
Yong Sang Hong South Korea
Takako Eguchi Nakajima Japan
A. Roth Switzerland
Kyu‐pyo Kim South Korea
Arnaud D. Roth Switzerland
Pascal Artru France
Laëtitia Dahan France
John Souglakos Greece
Roger Faroux relative to Benjamin R. Tan United States Benjamin R. Tan's profile →
Citations per field
00.5×1.5×1.8×
Benjamin R. Tan · 1×
Citations per year

Countries citing papers authored by Roger Faroux

Since Specialization
Citations

This map shows the geographic impact of Roger Faroux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Faroux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Faroux more than expected).

Fields of papers citing papers by Roger Faroux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Faroux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Faroux. The network helps show where Roger Faroux may publish in the future.

Co-authors

The 25 scholars most cited alongside Roger Faroux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roger Faroux Line = papers co-authored together Roger Faroux links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.

#Work
1
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Hit paper breakdown →
20182184
2
Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial
Hit paper breakdown →
2005817
3
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study
Hit paper breakdown →
2019410
4
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Hit paper breakdown →
2022225
5 2010133
6 2018129
7 2020126
8 2019110
9 2019100
10 201999
11 201790
12 201386
13 200882
14 201578
15 201276
16 198875
17 201874
18 201473
19 200772
20 201770

About Roger Faroux

Roger Faroux is a scholar working on Oncology, Hepatology, Gastroenterology, Pharmacology and Surgery, having authored 88 papers that have together received 6.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (37 papers), Colorectal Cancer Surgical Treatments (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Gastrointestinal Bleeding Diagnosis and Treatment (7 papers), Pharmacogenetics and Drug Metabolism (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Genetic factors in colorectal cancer (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (3.9k citations), Hepatology (265 citations), Cancer Research (309 citations), Pharmacology (211 citations) and Geriatrics and Gerontology (67 citations). Roger Faroux has collaborated with scholars based in France, Belgium and Germany. Frequent co-authors include Julien Taı̈eb, Michel Pierre Ducreux, Gérard Lledo, Thierry André, Christophe Louvet, Aimery de Gramont, Céline Lepère, Maria Giulia Zampino, Alberto Zaniboni and Enrico Aitini. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Digestive and Liver Disease, Journal of Hepatology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact